Literature DB >> 11841375

The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre.

P G M van der Valk1, G Moret, L A L M Kiemeney.   

Abstract

BACKGROUND: Data on the natural history and prognostic variables of chronic urticaria and its subtypes are scarce.
METHOD: In order to inform our patients better about their prognosis we conducted an historical cohort study of patients who visited a tertiary referral centre at a university hospital between 1968 and 1990. Of 950 patients who were seen in our clinic we could trace 544 patients by using telephone directories, general practitioner records and population registers. These patients were sent a questionnaire.
RESULTS: The response to the questionnaire was 68.4% (372 patients). Patients with severe disease and longer lasting disease at the time of the first visit proved to have a worse prognosis than patients with milder disease. The proportion cleared after 5 and 10 years was 29% and 44%, respectively. Dermographism showed the best prognosis and cold urticaria the worst. Patients with idiopathic urticaria without angioedema and the patients with angioedema did not differ significantly in prognosis.
CONCLUSIONS: Although in this retrospective study patients with severe disease may have been more inclined to respond, we may conclude that the study results indicate a very refractory course of chronic urticaria in patients visiting a specialized dermatological unit. The study is not comparable with studies in patients visiting a general practitioner or a dermatology unit in a general hospital, but highlights the chronicity of the disease in this subgroup of patients with severe urticaria.

Entities:  

Mesh:

Year:  2002        PMID: 11841375     DOI: 10.1046/j.1365-2133.2002.04582.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  25 in total

Review 1.  [Current position of the role of allergic and non-allergic food hypersensitivity in urticaria].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

2.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 4.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Urticaria: its history-based diagnosis and etiologically oriented treatment.

Authors:  Marcus Maurer; Jürgen Grabbe
Journal:  Dtsch Arztebl Int       Date:  2008-06-20       Impact factor: 5.594

6.  Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria.

Authors:  Teruhiko Makino; Yoshiaki Takegami; Mati Ur Rehman; Yoko Yoshihisa; Waka Ishida; Takashi Toyomoto; Tadamichi Shimizu
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-09-19

7.  H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study.

Authors:  Karsten Weller; Claudia Ziege; Petra Staubach; Knut Brockow; Frank Siebenhaar; Karoline Krause; Sabine Altrichter; Martin K Church; Marcus Maurer
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

8.  Urticaria and infections.

Authors:  Bettina Wedi; Ulrike Raap; Dorothea Wieczorek; Alexander Kapp
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-01       Impact factor: 3.406

9.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

10.  Effects of omalizumab treatment in patients with refractory chronic urticaria.

Authors:  Young-Hee Nam; Joo-Hee Kim; Hyun Jung Jin; Eui-Kyung Hwang; Yoo-Seob Shin; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-04-20       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.